Logo image of SI

SILVERGATE CAPITAL CORP-CL A (SI) Stock Fundamental Analysis

NYSE:SI - New York Stock Exchange, Inc. - US82837P4081 - Common Stock - Currency: USD

1.25  +0.01 (+0.81%)

After market: 1.29 +0.04 (+3.2%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SI. SI was compared to 396 industry peers in the Banks industry. SI may be in some trouble as it scores bad on both profitability and health. SI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SI had positive earnings in the past year.
Of the past 5 years SI 4 years were profitable.
SI had negative operating cash flow in 4 of the past 5 years.
SI Yearly Net Income VS EBIT VS OCF VS FCFSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M

1.2 Ratios

SI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SI Yearly ROA, ROE, ROICSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

In the last couple of years the Profit Margin of SI has grown nicely.
SI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y76.44%
PM growth 5Y56.45%
GM growth 3YN/A
GM growth 5YN/A
SI Yearly Profit, Operating, Gross MarginsSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 50 100 150

More info and screens

1

2. Health

2.1 Basic Checks

SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SI has more shares outstanding
SI has a worse debt/assets ratio than last year.
SI Yearly Shares OutstandingSI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
SI Yearly Total Debt VS Total AssetsSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

SI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SI (0.03) is better than 81.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.73%
SI Yearly LT Debt VS Equity VS FCFSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SI Yearly Current Assets VS Current LiabilitesSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.34% over the past year.
The Revenue for SI has decreased by -446.38% in the past year. This is quite bad
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)-446.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1791.86%

3.2 Future

The Earnings Per Share is expected to decrease by -19.40% on average over the next years. This is quite bad
Based on estimates for the next years, SI will show a very strong growth in Revenue. The Revenue will grow by 32.89% on average per year.
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-19.4%
EPS Next 5YN/A
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y32.89%
Revenue Next 5YN/A

3.3 Evolution

SI Yearly Revenue VS EstimatesSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M
SI Yearly EPS VS EstimatesSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.34, which indicates a rather cheap valuation of SI.
Based on the Price/Earnings ratio, SI is valued cheaper than 99.77% of the companies in the same industry.
SI is valuated cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 3.47, the valuation of SI can be described as very cheap.
96.96% of the companies in the same industry are more expensive than SI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SI to the average of the S&P500 Index (22.39), we can say SI is valued rather cheaply.
Industry RankSector Rank
PE 0.34
Fwd PE 3.47
SI Price Earnings VS Forward Price EarningsSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SI Per share dataSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

A cheap valuation may be justified as SI's earnings are expected to decrease with -19.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.1%
EPS Next 3Y-19.4%

More info and screens

0

5. Dividend

5.1 Amount

SI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILVERGATE CAPITAL CORP-CL A

NYSE:SI (5/10/2023, 8:22:59 PM)

After market: 1.29 +0.04 (+3.2%)

1.25

+0.01 (+0.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-24 2023-04-24/bmo
Earnings (Next)07-17 2023-07-17/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners0.31%
Ins Owner Change0%
Market Cap39.57M
Analysts35.56
Price Target4.08 (226.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.86%
Min EPS beat(2)-27.65%
Max EPS beat(2)-10.07%
EPS beat(4)2
Avg EPS beat(4)16.63%
Min EPS beat(4)-27.65%
Max EPS beat(4)73.14%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.79%
Min Revenue beat(2)-13.56%
Max Revenue beat(2)-4.02%
Revenue beat(4)2
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-13.56%
Max Revenue beat(4)7.75%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-74.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2602.7%
EPS NY rev (1m)-43.24%
EPS NY rev (3m)-91.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.08%
Revenue NY rev (1m)-11.89%
Revenue NY rev (3m)-60.22%
Valuation
Industry RankSector Rank
PE 0.34
Fwd PE 3.47
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)3.68
EY294.4%
EPS(NY)0.36
Fwd EY28.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS-19.1
BVpS19.05
TBVpS19.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y76.44%
PM growth 5Y56.45%
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover-0.05
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score0
WACC7.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-19.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-446.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1791.86%
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y32.89%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-53.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A